We observed that two strains of REV-T differ in the ability to transform bursal cells in vitro. REV-TW, with v-rel derived from a well-characterized clone and considered the prototype of the wild type, fails to generate colonies in soft agar. In contrast, REV-S2A3, derived from the S2A3 cell line, readily transforms bursal cells. 
Several aspects of transformation by v-rel render this oncogene an attractive tool for investigating the pathogenesis of hematological malignancies. v-rel is the transforming gene of avian reticuloendotheliosis virus strain T (REV-T).
This virus is one of the most virulent oncogenic retroviruses, causing death in 7 to 10 days from polyclonal lymphoid neoplasias after injection into newly hatched chickens (20, 59) . The v-Rel oncoprotein belongs to the NF-B/Rel family of transcription factors that includes the dorsal morphogen in Drosophila melanogaster, NF-B1 (p105/p50), NF-B2 (p100/p52), RelA (p65), RelB, and Rel (4, 19, 34, 46, 48, 52) . After binding to B sites, members of this class of molecules modulate the transcription of genes involved in embryogenesis, immune response, inflammation, and viral replication (2, 12, 22, 38) . Homodimerization or heterodimerization is a prerequisite for transactivation, and the combinatorial possibilities considerably expand the range of target genes (50) . The activity of the members of this family is regulated by a set of inhibitory factors including IB-␣, IB-␥, Bcl-3, and cactus. These proteins contain five to eight copies of the ankyrin repeat and function by sequestering NF-B/Rel complexes in the cytoplasm and inhibiting their binding to DNA in the nucleus (3, 10, 31, 32, 38) . The members of the NF-B/Rel family share the Rel homology region that encompasses 300 N-terminal amino acids and mediates DNA binding, dimerization, nuclear targeting, and interactions with inhibitor proteins. The N-terminal motif RxxRxRxxC has recently been found to be essential for DNA binding and is conserved in all NF-B/Rel proteins (36, 40) . In v-Rel, this sequence is located between amino acids 27 and 35 (56, 62) .
The v-rel oncogene is a truncated and mutated form of turkey c-rel. v-Rel is actually an Env-Rel-Env fusion protein containing 11 Env-derived amino acids in place of the first 2 amino acids of the c-Rel protein, 474 c-Rel-derived amino acids, and 18 amino acids derived from out-of-frame Env sequences at its C terminus which replace the terminal 118 amino acids of c-Rel. In addition, v-Rel contains 14 amino acid substitutions and three small deletions compared with c-Rel (12, 62) . The exact contribution of each of these changes to the activation of the full oncogenic potential of c-Rel is not known (20) . It is conceivable that each modification brought about a discrete increment in the transforming activity and that v-rel represents the result of an evolutionary process under strong selective pressure favoring a more tumorigenic phenotype (45) . In accordance with this notion, one would expect to find additional mutations with enhanced transforming ability. v-rel was transduced once and transforms only avian cells. Avian v-rel expressed from a murine retrovirus caused a cytopathic effect in mouse fibroblasts and bone marrow cells and produced no transformation. The inability to transform murine cells has been ascribed to this cytopathic effect (55) . However, activation through rearrangement of REL, NFKB2, and BCL-3 has been implicated in the pathogenesis of human lymphoid malignancies (31, 39, 46, 49, 63) . The full range of target cells susceptible to transformation by v-rel remains to be defined. Immature lymphoid cells, B cells, T cells, myeloid cells, and fibroblasts have been reported to be transformed by REV-T (5, 7, 8, 20, 37, 42, 43, 65, 66) . A number of factors have been considered to be important in determining the type of cell rendered neoplastic, including the age of the animal and the type of helper virus used (6) .
Most of the in vitro studies done have analyzed the generation of colonies in soft agar by splenocytes after infection with REV-T (24) . While carrying out similar experiments with bursal cells, we became aware that two strains of REV-T differ in the ability to transform B lymphocytes. The virus derived from nonproducer cell line S2A3 (6, 37) transforms B cells with high efficiency in both liquid and soft agar assays, while the wild type (14, 45, 62) fails to do so. The experiments described in the present report were aimed at establishing the molecular basis for this difference. We demonstrate that substitution of serine for alanine at position 40 of the v-Rel protein accounts for this enhanced oncogenic potential towards B lymphocytes. This gain-of-function mutation is located near the DNAbinding site. In electrophoretic mobility shift assays using in vitro translation products, the mutant v-Rel oncoprotein binds a B site more avidly than does the wild type.
MATERIALS AND METHODS
Plasmids and retroviruses used. All recombinant DNA manipulations were performed in accordance with standard procedures (53) . Unless otherwise specified, the pTZ-18R phagemid (Bio-Rad Laboratories, Richmond, Calif.) served as the vector for the constructs used. pREV-T3 is a circularly permuted clone of transforming REV-T DNA containing a single long terminal repeat and was cloned into the SalI site of pBR322 (14) . pREV-T10 was derived from REV-T3 by adding a 5Ј long terminal repeat and a leader sequence, thus completing the viral genome (45) . pREV-0 is a pREV-T3-derived vector designed for expression of exogenous genes in avian cells. Briefly, the REV-T3 clone was transferred from pBR322 to pTZ-18R, the viral structure was completed by addition of a 5Ј long terminal repeat and leader sequences, XhoI and BssHII sites were created in noncoding regions, and v-rel was replaced by a short, synthetic XhoI-BssHII fragment (45) . pREV-TW was constructed by insertion of an XbaI-NruI fragment containing all of v-rel from pREV-T3 into the XhoI-BssHII site of pREV-0 by using intermediate plasmid pTZXN-R containing a synthetic XhoI-XbaI-NruI-BssHII adaptor (45) . v-rel from the REV-T provirus present in the S2A3 cell line (REV-S2A3) was amplified five times by PCR and directly inserted into pREV-0 to create five independent clones, pREV-PCR1 to pREV-PCR5. The plasmids for hybrid retroviruses pREVpcrTW and pREV-twPCR were obtained by exchanging a 478-bp XhoI-ClaI fragment, coding for the first 148 amino acids of v-Rel, between pREV-TW and pREV-PCR1 (Fig. 1) .
For in vitro translation experiments, v-rel genes from pREV-pcrTW and pREV-twPCR were inserted into pTZXN-R (45) as XhoI-BssHII fragments.
pCSV11S3 is a genomic clone of chicken syncytial virus (CSV) isolated in this laboratory from the 11S3 cell line (7) . This retrovirus was used as a helper virus in all of the experiments described here. Plasmid pREVA6 was used to obtain the viral stocks of REV-A utilized in immunocytochemical assays (25) .
PCR cloning. PCR amplification of all of v-rel from the REV-T provirus present in cell line S2A3 was done with the following oligomers: 5Ј-ACTCTC GAGTCTAGAAAGCTCCTG-3Ј, spanning positions Ϫ37 to Ϫ14 with respect to v-rel and containing a C-to-G change at position Ϫ29, creating an XhoI site, and 5Ј-CGTTTCCGCGCGCCAAGGTC-3Ј, complementary to positions ϩ45 to ϩ26 and including a T-to-G change at position ϩ33 and an A-to-C change at position ϩ38, converting an NruI site to a BssHII site (Fig. 2) (56, 62) . The reaction mixture was subjected to 30 cycles of amplification (94ЊC for 70 s, 55ЊC for 60 s, and 72ЊC for 180 s) followed by a 7-min extension at 72ЊC with a thermal cycler and the GeneAmp kit (Perkin-Elmer, Norwalk, Conn.). The 1,591-bp amplified fragment was isolated by polyacrylamide gel electrophoresis after digestion with XhoI and BssHII and inserted into the XhoI-BssHII site of pREV-0. The products of five independent amplifications were used to generate pREV-PCR1 to pREV-PCR5.
Nucleotide sequence determination was performed by the dideoxy-chain termination method on single-strand phagemids with custom-made primers and T7 DNA polymerase (Sequenase; U.S. Biochemical, Cleveland, Ohio).
Chickens, cell lines, and media. Embryonated SC eggs were purchased from Hyline International Hatcheries (Dallas Center, Iowa) and incubated with humidity at 39ЊC. For transformation experiments, the animals were sacrificed 3 to 5 weeks after hatching. S2A3 is a nonproducer cell line developed in the laboratory of H. R. Bose by in vitro infection of spleen cells with REV-T (6, 37). Chicken embryonic fibroblasts (CEF) were prepared from 10-day-old embryos. All in vitro cell cultures used Dulbecco's modified Eagle's medium supplemented with 10% bovine calf serum (HyClone Laboratories, Inc., Logan, Utah), 5% chicken serum (GIBCO Biologicals, Grand Island, N.Y.), 10% tryptose phosphate broth (Difco Laboratories, Detroit, Mich.), 50 M 2-mercaptoethanol, and antibiotics (penicillin G at 100 U/ml and streptomycin at 50 g/ml).
Generation of virus stocks and virus titrations. Transfection of fibroblasts was performed by using a modified calcium phosphate procedure as described elsewhere (53) . Exponentially growing CEF were plated at 5 ϫ 10 5 cells per 90-mm-diameter tissue culture dish and cotransfected with 20 g of a plasmid containing a replication-defective retrovirus (pREV-TW, pREV-T10, pREV-T3, pREV-PCR1-5, pREV-pcrTW, or pREV-twPCR) and 2 g of plasmid pCSV 11S3, containing replication-competent helper virus CSV. pREV-T3 was digested with SalI and ligated before transfection. Adequate expression of genes from both viruses was verified by immunofluorescence. REV-A stocks were obtained by transfection of CEF with 2 g of plasmid pREVA6. Virus stocks were harvested after 6 days of culture and stored frozen.
The infectious titers of the replication-defective viruses and the CSV helper virus were determined by a modification of the quantitative immunocytochemical assay (25, 57) . Secondary cultures of CEF were plated at 7 ϫ ml of virus dilutions and incubated for 1 h at 37ЊC. For titration of the v-rel-coding viruses, the CEF were then superinfected with 10 6 infectious units of REV-A for 1 h. After addition of 4 ml of fresh medium, the plates were incubated for 48 h and then washed in phosphate-buffered saline (PBS), fixed in 2% paraformaldehyde in PBS, and stained for the presence of the v-Rel protein.
For titration of CSV, the CEF were overlaid with medium containing 0.7% agar and processed in a similar fashion. Monoclonal antibody HY87 was used to detect the v-Rel protein in the titration of the replication-defective viruses, and monoclonal antibody HY83 was utilized for assay of the CSV helper virus. After addition of biotinylated goat anti-mouse immunoglobulin antibody and streptavidin-linked alkaline phosphatase, foci of immunoreactive cells were scored with a microscope (anti-v-Rel antibody) or by eye (anti-CSV antibody).
Transformation assays. Bursal or splenic cells were isolated from fresh tissues taken from 3-to 5-week-old SC chickens. Cells (1.2 ϫ 10 7 ) were incubated with the appropriate dilution of the viral stock at 37ЊC in 200 to 300 l for 1 h. After addition of culture medium, the infected cells were transferred to 24 wells in 96-well trays for the liquid assay or to two 60-mm-diameter petri dishes in 0.35% agar for the soft agar assay. The number of wells containing at least one colony of any size (total colonies) was scored after 8 days of incubation at 37ЊC. Colonies were defined as large if single, easily seen by eye, and associated with yellow discoloration of the medium. The macroscopic colonies formed in soft agar were scored after 14 days of incubation at 37ЊC. The results are expressed as the number of colonies per milliliter of viral stock.
Indirect immunofluorescence and antibodies. Cells from single colonies generated in liquid or soft agar transformation assays were subcultured in 1 ml of medium in 24-well tissue culture trays. After 3 days, 10 5 cells were cytocentrifuged onto microscope slides, air dried, fixed in methanol-acetone (1:1) for 5 min, washed three times with PBS, and incubated for 30 min in 0.1% bovine serum albumin in PBS. The slides were then incubated for 1 h with hybridoma supernatant containing a monoclonal antibody diluted 1:1, washed with PBS, and incubated for 1 h with a fluorescein isothiocyanate-conjugated goat anti-mouse immunoglobulin antibody. Slides were washed three times in PBS, with the final wash overnight, and mounted with Fluoromount-G (Southern Biotechnology Associates, Birmingham, Ala.). The intensity of staining was analyzed under a fluorescence microscope.
The following monoclonal antibodies were employed: HY19 anti-chicken immunoglobulin M; HY83 anti-CSV, HY87 anti-v-Rel protein, and CT-3 antichicken CD3 (13, 25) .
In vitro translation and electrophoretic mobility shift assay. v-rel genes derived from pREV-twPCR (wild type) and pREV-pcrTW (mutant) were introduced into pTZ-18R-based plasmid pTZXN-R as described above. The v-Rel proteins were produced by using the Promega T7 TnT wheat germ extract coupled transcription-translation system in accordance with the protocol of the manufacturer. The relative yield of translation products was estimated by Western immunoblotting (53) . A 32 P-labeled DNA probe was prepared by annealing the 27-base template 5Ј-CAACGGCAGGGGAATCTCCCTCTCC TT-3Ј to the complementary 10-base primer 5Ј-AAGGAGAGGG-3Ј and filling the overhang with the Klenow fragment of DNA polymerase I essentially as described by Ballard et al. (4) . The template used corresponds to the B enhancer present in the interleukin-2 receptor ␣ promoter (4). By using in vitro translation products, DNA-binding reactions were carried out at room temperature for 30 min in 10 mM Tris-HCl (pH 7.5)-50 mM KCl-1 mM EDTA-5% glycerol in the presence of 0.2 ng (30,000 cpm) of radioactive probe and 2 g of poly(dI-dC) (Pharmacia, Piscataway, N.J.). The resulting complexes were resolved by 5% nondenaturing polyacrylamide gels and visualized by autoradiography overnight at room temperature. (20, 59) . REV-T has been independently cloned and characterized by two groups, and the nucleotide sequence of v-rel was found to be identical (14, 56, 62) . pREV-T3 is the clone used by Chen and Temin (14) and is considered the prototype of the wild type. pREV-TW was constructed in our laboratory by inserting v-rel from pREV-T3 into pREV-0, a retroviral vector also derived from pREV-T3 (45) . S2A3 is one of the several nonproducer cell lines obtained by Bose et al. by infecting avian hematopoietic cells with uncloned REV-T (37). Infectious stocks of this virus were obtained after superinfecting the S2A3 cell line with the CSV helper virus. When comparing the in vitro properties of REV-TW and REV-S2A3, we observed a higher efficiency of bursal cell transformation by the S2A3 strain. Only this virus was able to generate colonies in soft agar and to form large clones in liquid assays ( Fig. 1 and Table 1 ).
RESULTS

REV-S2A3 transforms bursal cells more efficiently than does wild-type REV-T. REV-T is the only naturally occurring retroviral isolate that encodes v-rel
v-rel accounts for enhanced B-cell transformation by REV-S2A3. Two mechanisms could explain the above observations. Differences in the non-v-rel part of the viral genome could influence the level of v-rel expression. Transformation of B cells may require a higher concentration of v-Rel protein than transformation of other hematopoietic cells, and this requirement is met only by REV-S2A3. Alternatively, the two viruses encode structurally distinct forms of v-rel with unique oncogenic potentials. Northern studies of cell lines infected with the two viruses failed to show a significant difference in RNA expression (data not shown). On the basis of these preliminary results, we tested the hypothesis that REV-S2A3 codes for a mutant v-rel with enhanced ability to transform B cells. The strategy followed was to compare the two oncogenes directly against the same REV-TW background by inserting v-rel from REV-S2A3 into REV-0 (Fig. 1) . Southern blot analysis demonstrated the existence of only one v-rel-containing provirus in cell line S2A3, indicating that a single molecular species of REV-T was responsible for the altered phenotype (data not shown). PCR amplification of v-rel from S2A3 cells was done with a 5Ј primer containing an XhoI site and a 3Ј primer containing a BssHII site. A 1,591-bp fragment was isolated and cloned into pREV-0 by using the XhoI and BssHII sites. This procedure resulted in three base pair changes outside v-rel compared with the published sequence of REV-T (56, 62) . Five clones of pREV-PCR, each produced by an independent amplification, were obtained.
The pREV-PCR plasmids were cotransfected with pCSV 11S3 into CEF to obtain REV-PCR(CSV) viral stocks. Immunofluorescence studies confirmed the expression in fibroblasts of v-Rel encoded by the recombinant plasmids (data not shown). We then tested the ability of REV-PCR1 to REV-PCR4 to form bursal cell colonies in liquid culture assays and compared it with that of REV-S2A3, REV-TW, REV-T10, and REV-T3. These experiments delineated two distinct phenotypes (Fig. 1) . Only the retroviruses containing v-rel from REV-S2A3 generated large colonies. These are easily recognizable by the change in medium color from pink to yellow caused by a drop in pH as the cell number per well approaches 10 6 (see below). In calculating the titer of large CFU; we took into account only the wells with a single colony, since the yellow discoloration could also be due to multiple colonies with limited numbers of cells. On the other hand, REV-TW, REV-T10, and REV-T3, all related genealogically and encoding the same wild-type v-rel, formed only small colonies. These An alanine-to-serine mutation at position 40 of the v-Rel protein confers B-cell-transforming activity. To define the structural basis for this difference, the entire v-rel genes and the flanking segments from both REV-TW and REV-PCR1 were sequenced. Two mutations were found in the 5Ј region of v-rel from REV-PCR1: a silent mutation at codon 33 and a G-to-T transversion, changing the alanine at position 40 to serine (Fig. 2B) . These two mutations were also present in the other four REV-PCR viruses and thus do not represent PCR-induced artifacts. The v-rel sequence from REV-TW was found to be identical to the published one (56, 62) , confirming the wild-type genotype of this virus. 5Ј of v-rel, both REV-TW and REV-PCR1 have the expected change from C to G at position Ϫ29, creating the XhoI site used for cloning ( Fig. 2A) . In REV-PCR1, analysis of the sequences 3Ј of v-rel revealed the anticipated changes from T to G and from A to C at positions ϩ33 and ϩ38, respectively, converting the NruI site into a BssHII site (Fig. 2C) . The sequence of REV-TW 3Ј of v-rel contains an extra 21 bp, starting at position ϩ36. This stretch represents an unexpected cloning artifact and includes a 15-bp repeat of the sequence from position ϩ21 to position ϩ35 and 6 bp introduced to create the BssHII site (Fig. 2C) . The above alterations outside v-rel may not be relevant to the oncogenic properties of REV-TW, since they are located in noncoding parts of the viral genome. These changes, however, could modulate the expression of v-rel. The only structural modification of v-Rel that can account for the increased transformation of B cells by REV-S2A3 is replacement of the wild-type alanine at position 40 with a serine (Fig. 2D) .
To establish the pathogenic relevance of this mutation, two hybrid retroviruses were constructed by exchanging the XhoIClaI fragment (478 bp), coding for the first 148 amino acids of the v-Rel protein, between REV-TW and REV-PCR1. These chimeric constructs are designated REV-pcrTW (serine at position 40) and REV-twPCR (alanine at position 40) (Fig. 1) . The exchange was verified by DNA sequence analysis of the mutation site and of the flanking sequences 3Ј of v-rel. After transfection into CEF to rescue the viruses, the transforming activities of the two viruses and the parental strains were compared. Only the mutant viruses were able to form large colonies of B cells in liquid culture (Fig. 1) . The 15-bp repeat present in the 3Ј part of REV-TW does not inhibit transformation, since REV-pcrTW contains this sequence and is fully oncogenic. On the other hand, REV-twPCR, which lacks the two mutations and codes for an alanine at position 40 but is otherwise identical to transforming REV-PCR1, displays the weakly oncogenic phenotype. Collectively, these results indicate that the change from alanine to serine at position 40 of the v-Rel protein correlates with the increased transformation of bursal cells by REV-S2A3 (Fig. 1) .
Comparison of the transforming properties of wild-type and mutant v-rel in vitro. The test that most clearly was able to differentiate between the two phenotypes was formation of macroscopic colonies of bursal cells in soft agar. On repeated experiments, REV-TW and REV-twPCR failed to generate colonies while the mutant viruses consistently scored positive results, although with a variable titer ( Table 1) . Particularly revealing was the comparison between REV-twPCR and REV-pcrTW. These two hybrid viruses were obtained with the same transfection and displayed similar titers on immunocytochemical assay (Fig. 1) , indicating that the two viral stocks contain comparable numbers of viral particles coding for the oncogene. However, only REV-pcrTW, coding for v-Rel with serine at position 40, can form colonies in soft agar. This assay is considered the best in vitro correlate of in vivo oncogenicity; however, the colony formation titers were variable and relatively low compared with the immunocytochemical titers. Higer titers and more consistent results were obtained by using the liquid transformation assay and scoring the formation of large colonies 8 days after infection. The large number of experiments done with this test are summarized in Fig. 1 . Although the sizes of the colonies formed a continuous spectrum, we found it useful to divide them into large and small ones. The large ones were defined by yellow discoloration of the medium as the cells accumulated in the wells and the pH decreased. The small ones only occasionally progressed to become large and tended to regress after day 8 of culture. The total numbers of colonies generated by the two groups of viruses were similar, with titers ranging from 10,000 to 50,000/ml (data not shown), confirming the comparable immunocytochemical titers. At the lower dilutions, several wells turned yellow, reflecting the presence of multiple colonies. Accordingly, the exact titer of large-colony production by the wild-type viruses is not known. On the other hand, approximately one of every two single-hit colonies generated by the mutant viruses was scored as large on day 8 (Fig. 1) . The remaining colonies were of considerable size and commonly progressed to cause a yellow discoloration in 2 to 3 days. The trays displayed two distinct color patterns that consistently mirrored the genotypes of the viruses. To have more insight into the effects of this gain-of-function mutation, we compared some aspects of the proliferative activity of bursal cell colonies induced by the two forms of v-rel. Average cell counts of wells containing single colonies revealed a 10-fold difference between the two types of virus (Table 1) . Interestingly, the clones induced by the wild-type viruses had a much higher percentage of dead cells (30 versus 5%; data not shown), indicating that the small colonies may represent transient proliferation of cells destined to die and not full-fledged transformation. We studied the ability of the clones to be passaged 10 times as an indicator of immortalization by different forms of v-rel. Only 10 to 20% of the clones generated by the wild type passed that mark, while 85 to 95% of the clones driven by the mutant oncoprotein could be cultured for 10 passages (Table 1 ). These data indicate that the mutant v-rel confers an increased proliferative activity on B cells.
We were interested in determining if the mutant viruses transform other cell types more efficiently. Parallel experiments were performed with spleen cells as the target (Table 2) . The soft agar assay was not as discriminatory as for bursal cells, since the wild-type viruses were also able to generate colonies, although at a titer lower than that of the mutant viruses. The same trend was apparent in the liquid assay, where an approximately 10-fold difference in the titer of large colony formation was observed. This is in contrast to the 100-fold difference for the same assay employing bursal cells. These data are consistent with the notion that the enhanced transforming ability of the REV-S2A3 type of virus is selective for B cells, while the two kinds of virus transform non-B cells with similar efficiencies. Immunophenotypic analysis of colonies derived from spleen cells supported this hypothesis. The REV-TW type of virus gave rise predominantly to T-cell or non-T, non-B-cell colonies, while the majority of the colonies produced by the mutant viruses were of B-cell origin (Table 3) .
Mutant v-Rel has increased DNA-binding activity. The v-Rel oncoprotein is believed to be pathogenic by acting as a transcription factor either activating or repressing gene expression after binding to enhancers containing the B motif (4, 16, 18, 27, 41, 54) . DNA-binding is a conserved property of 304 ROMERO AND HUMPHRIES J. VIROL.
on July 7, 2017 by guest http://jvi.asm.org/ transforming v-Rel proteins (4, 11, 28, 35, 60, 61) . The mutated residue is located very close to the putative DNA-binding site encompassing amino acids 27 to 35 (36, 40) . The change from alanine to serine at position 40 could significantly affect the DNA-protein interaction. We tested this possibility in an electrophoretic mobility shift assay using in vitro-translated proteins and an oligomer containing the B element present in the promoter of the interleukin-2 receptor ␣ gene (4) . Figure  3 shows the results of a typical experiment with wheat germ extracts programmed with v-rel derived from REV-pcrTW (mutant) or REV-twPCR (wild type). Western blotting showed that the extracts contained equivalent amounts of the translation product (data not shown). v-Rel with serine at position 40 displayed a DNA-binding activity at least fivefold higher than that of the alanine-containing oncoprotein. In the presence of an excess of cold probe, the specific band was completely inhibited while the nonspecific binding activity present in the extract was not affected.
DISCUSSION
Malignant transformation is considered to be a multistep process. Many oncogenes transduced by retroviruses require the cooperation of another oncogene. Synergism between cytoplasmic and nuclear oncoproteins has been described in several experimental systems (26) . The unusually potent transforming activity of REV-T in vivo implies that v-Rel performs more than one function during tumorigenesis. In the present report, we describe a naturally occurring gain-of-function point mutation of this oncogene that specifically enhances the ability of the wild type to transform B lymphocytes in vitro. This variant of v-rel may provide a novel system for elucidating one function critical to B-cell transformation.
The structural requirements for v-rel-induced oncogenesis have been extensively investigated by using a number of artificial constructs and mutants. Alterations in both the Rel homology region and the C terminus are required for transformation (9, 17, 29, 43, 45, 54, 58, 60) . The data collected so far do not conclusively favor one of the different pathogenetic models that have been proposed (20) . Acting as a transdominant factor, v-Rel could repress or activate transcription of critical genes either by occupying B sites directly or by forming inactive complexes with other Rel proteins or IB molecules, respectively. The latter indirect models are consistent with the observation that v-Rel is primarily cytoplasmic in transformed splenocytes (21) . Furthermore, mutated forms of v-Rel can act either in the nucleus or in the cytoplasm to transform spleen cells and to activate transcription (23) proteins (4, 27, 41, 44, 51) . However, other studies have suggested that transforming forms of v-Rel activate transcription from promoters containing B sites (16, 18, 25, 45, 54, 60) .
The data obtained with the REV-PCR viruses indicated that v-rel derived from the S2A3 cell line confers the ability to transform bursal cells efficiently. Sequence analysis confirmed that REV-TW codes for a v-rel identical to the one already characterized and considered the wild type (14, 56, 62) . All of the REV-PCR viruses, coding for a v-rel derived from REV-S2A3, contained a mutation changing the alanine at position 40 to serine. The experiments with the hybrid viruses established the importance of this change for efficient B-lymphocyte transformation. The mutant v-rel confers an expanded proliferative potential on infected B cells. This was manifested by increased colony size in liquid culture and colony formation in soft agar.
As a biochemical correlate of the enhanced transforming activity, we have shown that the serine at position 40 increases the ability of v-Rel to bind a B site. This finding is consistent with the observation that residues 27 to 35 of v-Rel are involved in redox regulation of DNA binding (36, 40) . Recently, a temperature-sensitive transforming mutant of v-rel was obtained by changing codon 37 from glycine to glutamic acid. The resultant v-Rel protein was temperature sensitive for DNA binding, confirming the notion that the latter function is critical in transformation (61) . The N-terminal 50 residues of the c-Rel protein have been reported to mediate the interaction with the inhibitor IB and the TATA-binding protein (32, 33) . The v-Rel oncoprotein was unable to bind the latter polypeptide (33) . However, these findings are somewhat controversial, since another group has implicated the C-terminal activation domains of c-Rel and v-Rel in the association with the TATA-binding protein and transcription factor IIB (64) . Alterations in each of the above interactions can be envisioned to affect the transforming ability of v-rel through transcriptional modulation of critical genes. It is also possible that some other function, like dimerization or binding to a novel protein, could be altered by the mutation. The serine is not located in a typical recognition motif for the known protein kinases, although the RXS sequence can be phosphorylated in vitro by cyclic AMP-dependent protein kinase (30) . It remains to be shown if this posttranslational modification is involved in regulation of the activity of the mutant v-Rel.
The alanine at position 40 probably plays an important role since it is conserved in dorsal, RelA, RelB, and c-Rel (48, 52, 62) . A histidine replaces alanine in NF-B1 and NF-B2, two homologous members of the family with distinctive features and separate evolutionary histories (19, 22, 46) . The above observation and the fact that an alanine is present in the two clones of v-rel characterized in the past (56, 62) suggest that REV-S2A3 arose because of a mutation of a REV-T3 type of virus and not vice versa.
Our data indicate that the main effect of the mutation is to expand the ability to transform B lymphocytes, rather than general enhancement of the oncogenic potential toward all hematopoietic cells. This observation raises the possibility that a specific cellular component unique to B cells constitutes the target for the more active v-Rel protein. This target could be either a regulatory DNA element or a protein present in active form only in B cells. In retrospect, the present results may explain in part the efficient transformation of mature B cells observed in our previous studies (6, 7) . In these investigations, the S2A3 cell line was used to produce the stocks of REV-T(CSV) that readily induced immunoglobulin M-positive lymphomas and cell lines.
Three non-mutually exclusive mechanisms can account for the 10-fold difference in the sizes of the bursal cell colonies in liquid culture assays: (i) the cells transformed by mutant v-rel are prevented from entering G 0 and remain in cycle, (ii) the mutant oncogene enables B lymphocytes to escape the normal fate of programmed cell death, and (iii) wild-type v-Rel is more toxic for B cells, and the mutant oncoprotein is deficient in a function that is detrimental to B lymphocytes. The increased number of dead cells in the colonies generated by wild-type v-rel is consistent with the latter two explanations. Under some conditions, overexpression of c-rel induces apoptosis in avian bone marrow cells (1) . One of the functions of v-Rel could be prevention of c-Rel-mediated programmed cell death. A large proportion of oncogenes transduced by acutely transforming retroviruses are transcriptional stimulators. Furthermore, activation of transcription factors through chromosomal translocation is one of the most common pathogenetic mechanisms implicated in human hematological malignancies (15, 47) . However, the chain of events leading to subversion of the normal differentiation pattern and to unrestrained proliferation has not been elucidated. Nor has an explanation been provided for the association between activation of specific transcription factors and the cell lineage of the resulting malignancy. Further studies of the molecular consequences of this variant v-Rel may offer clues to the solution of the above problems.
